Moro, Ruth N <br/><br/>
Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials.  [electronic resource] 

 -  Annals of the American Thoracic Society  05 2018 
 - 570-580 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>2325-6621 
<br/><br/><label>Standard No.: </label>10.1513/AnnalsATS.201704-326OC  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antitubercular Agents--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Infant, Newborn<br/>Isoniazid--administration & dosage<br/>Latent Tuberculosis--drug therapy<br/>Middle Aged<br/>Pregnancy<br/>Pregnancy Complications, Infectious--drug therapy<br/>Pregnancy Outcome<br/>Rifampin--administration & dosage<br/>Young Adult